Global Journal of Cancer Therapy Submit Manuscript

    Introduction

    • Volume/IssueClick here
    • Review ProcessDouble Blind
      • Publication lead time3 - 4 weeks
      • Indexing statusYes; Purview
      • Manuscript Processing ChargesClick here
      • Submission ChargesNo
      • Waiver policy for APCYes
      • Language of Full TextEnglish
      • Full-text formats availablePDF, HTML
    • Show +
    • Articles digitally archived in PORTICO
    • Permanent article identifierDOI (Digital Object Identifier) We provide DOI to all published papers to facilitate higher citation and classification of articles.
      Peertechz Publisher ID: 10.17352
    • Type of LicenseCreative Commons
      • Open AccessYes; Policy
      • Does the author retain unrestricted copyright?Yes
      • Does the author retain publishing rights?Yes
    • Show +

    Editor-in-Chief

    M.Waheed Roomi

    M.Waheed Roomi
    Dr. Rath Research Institute
    1260 Memorex Drive, Santa Clara, USA
    Email: w.roomi@drrath.com
    Tel: (408)730-4481
    Fax: (408) 588-7174

    More Info.

    Tsuyoshi Shirakawa

    Tsuyoshi Shirakawa
    Kyushu University, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan
    Email: t-w-r@intmed1.med.kyushu-u.ac.jp
    Tel: +81-92-661-5395
    Fax: +81-955-70-1511

    More Info.


    Welcome from the desk of

    Dr. Tsuyoshi Shirakawa, MD., Executive Editor

    Welcome to our website! I am very happy for your visit.

    Global Journal of Cancer Therapy reports both clinical and experimental results related to cancer, and is using online review and Editorial Manager System for quality review process. The Journal invites all type of clinical and medical case reports, case studies, basic researches, clinical images, pharmacology and nursing, as it were, total oncology. The goal of us is to keep a record of the state-of-the-art research or case report and to promote study, research and improvement within its various specialties, then to develop total oncology.

    We believe your expertise knowledge will help in the growth of the journal and as well help many budding research scientists all around the world. Your article will be a key insight into real medical cases that are essential for physicians, and may ultimately help to improve patient outcomes.

    Editorial Board

    Ryou-U Takahashi
    Division of Molecular and Cellular Medicine
    National Cancer Center Research Institute
    Japan
    rytakaha@ncc.go.jp
    GJCT

    Research Interest: Molecular And Cell Biology, Microrna, Breast Cancer, Cancer Stem Cells


    More Info.
    Hikmat N Abdel-Razeq
    Deputy Director General
    King Hussein Cancer Center
    University of Jordan
    Jordan
    habdelrazeq@KHCC.JO
    GJCT

    Research Interest: Clinical Oncology

    More Info.
    Yan Baglo
    Research Fellow
    Fischell Department of Bioengineering
    University of Maryland
    USA
    ybaglo@umd.edu
    GJCT

    Research Interest: Cancer treatment regimens, photodynamic therapy, nanotechnology-enabled drug delivery.

    More Info.
    Ana Livia Silva Galbiatti
    Faculdade de Medicina de São José do Rio Preto
    Brazil
    analivia_sg@yahoo.com.br
    GJCT

    Research Interest: Head And Neck Cancer, Genetics, Molecular Biology, Cell Line, Chemoterapeutics, Genetic Polymorphisms


    More Info.
    Rajeev Shrivastava
    Department of Radiation Oncology
    Aditya Birla Memorial Hospital
    India
    dr_shriraj@yahoo.co.in
    GJCT

    Research Interest: Carcinoma Lung, Breast and Cervix

    More Info.
    Maryam Azimi Mohammadabadi
    Department of Immunology
    Tehran University of Medical Science
    Iran
    m-azimim@razi.tums.ac.ir
    GJCT

    Research Interest: Potential Therapeutic Applications of Arteether, a Semi-Synthetized Derivative of Artemisinin on a Murine Model of Breast Cancer. As a Result, I Have Got Some Experience Atan Area of Tumor Immunology/Immunotherapynamed "Chemoimmunotherapy". Chemoimmunotherapy is an Approach for the Treatment of Cancers in Whichthe Focus is to enhance the Efficacy of chemotherapeutic Agents by Concomitant Application of Compounds with Immunomodulatory Properties. Besides my Thesis Work, I Managed to Do a Course in Cellular Immunology with Professor Hassan, One of the Well-Knownimmunologists in Iran, so that i could also Work on Cellular Immunology Aspects of Tumors. Moreover, Considering the Reported Associations between Molecular Players such as CTLA-4, PDL-1 and also Different Micrornas in Tumor Progression, i am Currently Planning to further Study these Associations in order to improve the Efficacy of Tumor Immunotherapy

    More Info.
    Diana Bell
    Assistant Professor
    Department of Pathology
    MD Anderson Cancer Center
    USA
    diana.bell@mdanderson.org
    GJCT

    Research Interest: A dedicated head and neck pathologist, Bell’s research interest focuses on sinonasal and salivary gland tumors. The aim of her research is to find and apply new strategies and technologies to better understand key molecular changes during the pathogenesis of head and neck cancers, with emphasis on salivary gland and sinonasal tumors.


    More Info.
    Kailash Chadha
    Department of Molecular and Cellular Biology
    Roswell Park Cancer Institute
    USA
    Kailash.Chadha@RoswellPark.org
    GJCT

    Research Interest: The Physiological Role Of PSA In Prostate Tissue Microenvironment, In Prostate Tumor Growth And Progression, And In Prostate Cancer Metastasis Is Not Known. Attenuation Of PSA Levels With Age, Disease Progression, Or During Androgen Deprivation Therapy, However, Removes This Important Regulator Of Angiogenesis, And By Extension Results In Tumor Progression. Re-Introduction Of Human PSA Into The Prostate Tissue Microenvironment May Suppress Tumor Angiogenesis Through Either The Inhibition Of Expression Of Pro-Angiogenic Genes Or Induction Of Expression Of Anti-Angiogenic Genes, Or Via Inhibition Of Signaling Mechanisms Associated With Angiogenesis That Are Independent Of Gene Transcription. Validation Of An Anti-Angiogenic Effect Of PSA On The Human Tissue Vasculature In A Pre-Clinical Model Of Primary Xenografts Of Human Prostate And Prostate Cancer Tissue Will Provide Compelling Evidence That PSA Has Therapeutic Potential Against Prostate Cancer.



    More Info.
    Manzoor Ahmad Rather
    Division of Medicinal Chemistry
    Indian Institute of Integrative Medicine
    India
    manzooriiim@gmail.com
    GJCT

    Research Interest: Drug Discovery and Development from Plant Sources. Isolation and Characterization of Bioactive Molecules from High Altitude Medicinal and Aromatic Plants Using Different Separation Techniques Like TLC, Column Chromatography, Preparative TLC, HPLC, HPTLC, LC-MS, GC-FID And GC-MS. Characterization of the Isolated Molecules from the Plants Using Different Spectroscopic Techniques Like 1H NMR, 13C NMR, 2D Techniques, Mass Spectrometry, IR, X-Ray, UV- Visible Etc. Structural Modifications of these Molecules to Value Add their Biological Properties. Chemical Characterization Using Capillary GC-FID and GC-MS Analytical Techniques and Bioevaluation of Essential Oils, Oleoresins and Other Aroma Mixtures Isolated from Aromatic Plants with Main Thrust on Unexplored Flora of the Kashmir Valley

    More Info.
    Stefania Staibano
    Professor
    Department of Pathology
    University of Naples Federico II
    Italy
    staibano@unina.it
    GJCT

    Research Interest: Head And Neck Pathology Section At The Department Of Surgical Pathology


    More Info.
    Wei Du
    Hematology and Cancer Biology
    Cincinnati Childrens Hospital Medical Center
    USA
    Wei.Du@cchmc.org
    GJCT

    Research Interest: Stem Cell Biology And Pathophysiology Of Bone Marrow Failure And Leukemia; Identifying And Targeting The Alternative Oxidative DNA-Damage Response Pathways Required For Cancer Progression; The Role Of A Major Proliferating Protein, Nucleophosmin (NPM) In Cancer Development


    More Info.
    Zhu Shu
    Yale University
    USA
    shu.zhu@yale.edu
    GJCT

    Research Interest: To Study How Our Immune Systems Recognize “Self” (The Host) Or “Non-¬‐Self” (Foreign Material) Antigens, And How The Break Of These Processes Leads To The Consequent Disease Pathology, Including Infectious Diseases And Autoimmune Diseases.


    More Info.
    Gang Du
    Shanghai Jiaotong University
    China
    gdu@dbm.ecnu.edu.cn
    GJCT
    Research Interest: Clinical Tumour Classification And Diagnosis, Data Mining In Healthcare, Clinical Pathway Modeling, Simulation And Scheduling Optimization, Decision-Making In Healthcare  
    More Info.
    Raj Kumar Koiri
    Assistant Professor
    Department of Zoology
    Dr. Hari Singh Gour Central University
    India
    rkkoiri@dhsgsu.ac.in
    GJCT

    Research Interest: To study the metabolic adaptation for survival occurring in the cancer cells

    More Info.
    Tomasz Skora
    Gastrointestinal and Genitourinary Cancer
    Maria Sklodowska-Curie Memorial Institute
    Poland
    tbskora@gmail.com
    GJCT

    Research Interest: Radiotherapy, Proton Therapy, Particle Therapy, Gastrointestinal Cancers, Genitourinary Cancers, Anal Canal Cancer, Rectal Cancer, Gastric Cancer, Seminoma, Bladder Cancer, Prostate Cancer


    More Info.
    View more
    mendeley

    Clinical trials cannot provide sufficient accuracy for studying weak factors necessary for curing chronic diseases

    DOI Logo 10.17352/2581-5407.000044

    Published On: March 23, 2022 | Pages: 021 - 033

    Author(s): Jianqing Wu* and Ping Zha
    Abstract View Full Article View    
    mendeley

    Surgery, Chemotherapy and Radiotherapy May Promote Cancer Growth Speeds and Shorten Patient Lives

    DOI Logo 10.17352/2581-5407.000043

    Published On: March 19, 2022 | Pages: 001 - 020

    Author(s): Jianqing Wu* and Ping Zha
    Abstract View Full Article View    
    mendeley

    Patient’s experiences on receiving radiation therapy for head and neck cancer pre, pending and post treatment: A qualitative study at Bugando medical centre Mwanza, Tanzania

    DOI Logo 10.17352/2581-5407.000042

    Published On: August 23, 2021 | Pages: 046 - 049

    Author(s): Francis Kazoba* and Juston John
    Abstract View Full Article View    
    mendeley

    Assessment of the role of multimodality imaging for treatment volume definition of intracranial ependymal tumors: An original article

    DOI Logo 10.17352/2581-5407.000041

    Published On: July 06, 2021 | Pages: 043 - 045

    Author(s): Ferrat Dincoglan, Omer Sager*, Selcuk Demiral and Murat Beyzadeoglu
    Abstract View Full Article View    
    mendeley

    Mechanistic basis for Cancer Immune Evasion and role of immune checkpoint blockades in Immuno-Oncology

    DOI Logo 10.17352/2581-5407.000040

    Published On: May 19, 2021 | Pages: 035 - 042

    Author(s): Benjamin A Babalola*, Gboyega E Adebami and Samuel E Akinsuyi
    Abstract View Full Article View    
    mendeley

    Evaluation of changes in tumor volume following upfront chemotherapy for locally advanced Non Small Cell Lung Cancer (NSCLC)

    DOI Logo 10.17352/2581-5407.000039

    Published On: March 15, 2021 | Pages: 031 - 034

    Author(s): Omer Sager*, Ferrat Dincoglan, Selcuk Demiral and Murat Beyzadeoglu
    Abstract View Full Article View    
    mendeley

    Essentially new inhibitors of metastasis of malignant tumors for chemotherapy-sparing treatment

    DOI Logo 10.17352/2581-5407.000038

    Published On: February 24, 2021 | Pages: 016 - 030

    Author(s): ISh Nadiradze* and NSh Chigogidze
    Abstract View Full Article View    
    mendeley

    Disease biology alters the response to frontline bortezomib, lenalidomide and dexamethasone in Multiple Myeloma

    DOI Logo 10.17352/2581-5407.000037

    Published On: February 13, 2021 | Pages: 010 - 015

    Author(s): Amany R Keruakous*, Silas Day and Carrie Yuen
    Abstract View Full Article View    
    mendeley

    Application of nano based drug delivery channel against leukemia chemotherapeutic resistance

    DOI Logo 10.17352/2581-5407.000036

    Published On: February 09, 2021 | Pages: 001 - 009

    Author(s): Rahul Bhattacharjee*, Olabimtan Olabode H, Ochigbo Victor and Samuel Florence
    Abstract View Full Article View    
    mendeley

    Atypical Fibroadenoma Presentation of a Case

    DOI Logo 10.17352/2581-5407.000035

    Published On: November 10, 2020 | Pages: 042 - 044

    Author(s): Juana Teresa Santiago Pérez*, José Miguel González Barcena, Yuranis Gárciga Martin and Yahumara Suarez Morales
    Abstract View Full Article View    

     

    Clients' voices

    Readmore

    Indexing/Archiving

    Global Views

    Case Reports

    Peertechz Tweets

    Pinterest on GJCT

    Google Reviews 11